Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 872 of 1,261
  1. US 8440208

    Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  2. US 8440182

    Methods and compositions for treating phenylketonuria

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  3. US 8440168

    Image-guided therapy of myocardial disease: composition, manufacturing and applications

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  4. US 8440816

    Branched polymers

    Nektar Therapeutics · Granted May 14, 2013 · Expires May 9, 2033

    granted
  5. US 8440832

    Heterocyclic modulators of cannabinoid receptors

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  6. US 8440813

    Antiviral nucleoside analogs

    BioCryst Pharmaceuticals, Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  7. US 8440692

    Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents

    China Medical University · Granted May 14, 2013 · Expires May 9, 2033

    granted
  8. US 8440811

    DNA nanostructures that promote cell-cell interaction and use thereof

    Arizona Board of Regents, a Body Corporate acting for and on behalf of Arizona State University · Granted May 14, 2013 · Expires May 9, 2033

    granted
  9. US 8440652

    MST1 kinase inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  10. US 8440707

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  11. US 8440706

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted May 14, 2013 · Expires May 9, 2033

    granted
  12. US 8440722

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  13. US 8440721

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  14. US 8440679

    Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted
  15. US 8440667

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  16. US 8440787

    Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom

    Nektar Therapeutics · Granted May 14, 2013 · Expires May 9, 2033

    granted
  17. US 8440687

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted May 14, 2013 · Expires May 9, 2033

    granted
  18. US 8440460

    Methods for transdifferentiating cells

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  19. US 8440202

    Induction of an immune response against dengue virus using the prime-boost approach

    United States of America as represented by the Secretary of the Air Force · Granted May 14, 2013 · Expires May 9, 2033

    granted
  20. US 8435504

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics · Granted May 7, 2013 · Expires May 2, 2033

    granted
  21. US 8435960

    Devices for improved wound management

    Lakewood Amedex, Inc. · Granted May 7, 2013 · Expires May 2, 2033

    granted
  22. US 8435979

    Use of imipramine blue and analogs thereof in treating cancers

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted May 7, 2013 · Expires May 2, 2033

    granted
  23. US 8435995

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  24. US 8435941

    Mini-hepcidin peptides and methods of using thereof

    The Regents of the University of California · Granted May 7, 2013 · Expires May 2, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.